Clinical Trial Update: Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tolerability and efficacy of L-Serine in patients with amyotrophic lateral sclerosis; the study was terminated and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• L-serine (L-serine)

Snippet

Sponsor: Elijah W. Stommel | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: TERMINATED | Results posted: 2025-04-20